News
Dive into the latest news, press releases and reports from the Abacus Medicine Group.
Annual Report 2022: Profitability focus pays off for the Abacus Medicine Group
Increasing profitability was a declared target for the Group for 2022 and this was successfully achieved. Based on strong performance especially in the parallel distribution business EBITDA grew 58% to a record level of EUR 26.2 million.
Milestone: 1,000,000,000 euros
The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.
Abacus Medicine wins 12th Gazelle Award
The Gazelle is awarded by Børsen to the fastest-growing Danish companies of the year. Abacus Medicine has won its 12th Gazelle Award. This makes Abacus
Allan Dinesen appointed new Chief Operating Officer of the Abacus Medicine Group
Allan Dinesen becomes the fifth member of an expanded Chief Executive Management Team. The Abacus Medicine Group has appointed Allan Dinesen as its new Chief
Maria Addis appointed new Group Chief Financial Officer of the Abacus Medicine Group
The current CFO of media group Watch Medier joins Abacus Medicine on August 15, 2022. The Abacus Medicine Group has appointed Maria Addis as its
Abacus Medicine contributes to savings for the Danish pharmaceutical market
A report published by The Danish Association of Parallel Importers of Pharmaceuticals highlights the transformational impact of Parallel imports on the Danish pharmaceutical market. Key
